BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6358037)

  • 1. Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma.
    Koff WC; Showalter SD; Seniff DA; Hampar B
    Infect Immun; 1983 Dec; 42(3):1067-72. PubMed ID: 6358037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
    Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
    J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
    Pidgeon C; Schreiber RD; Schultz RM
    J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
    Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
    Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
    Schreiber RD; Altman A; Katz DH
    J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S; Poste G; Fidler IJ
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
    Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
    Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
    Kleinerman ES; Fogler WE; Fidler IJ
    J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
    Kanagawa O; Chiller JM
    J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum.
    Wu-Hsieh B; Zlotnik A; Howard DH
    Infect Immun; 1984 Jan; 43(1):380-5. PubMed ID: 6197379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production of a cytotoxic factor by mouse peritoneal macrophages and macrophage hybridomas treated with various stimulating agents.
    Takeda Y; Higuchi M; Sugimoto M; Shimoda O; Woo HJ; Shimada S; Osawa T
    Microbiol Immunol; 1986; 30(2):143-54. PubMed ID: 3086676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of C3 as a marker of lymphokine-mediated macrophage activation.
    Koestler TP; Kirsh R; Kline T; Rieman D; Greig R; Poste G
    Cell Immunol; 1984 Aug; 87(1):1-14. PubMed ID: 6378389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.